Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegvisomant Add-on to Somatostatin Analogs in Acromegaly
NCT00642720Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Oct 2006
- Primary completion
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised, double-blind trial in acromegaly comparing Pegvisomant First with Placebo First (2 arms). Primary endpoint: Quality of Life at 16 weeks. Started Oct 2006; status: completed.
02
Drugs
pegvisomant
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT00642720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00642720.